Binding patterns of BCL11A in the globin and GATA1 loci and characterization of the BCL11A fetal hemoglobin locus

Blood Cells, Molecules, and Diseases

Volumn 45, Issue 2, 2010, Pages 140-146

  Jawaid, Kiran ^a   Wahlberg, Karin ^a   Thein, Swee Lay ^a   Best, Steve ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

BCL11A; ChIP; GATA1; HbF; Hemoglobinopathies

Indexed keywords

ALPHA GLOBIN; BETA GLOBIN; HEMOGLOBIN F; HISTONE H3; PROTEIN BCL11A; REGULATOR PROTEIN; TRANSCRIPTION FACTOR GATA 1; UNCLASSIFIED DRUG;

ARTICLE; BINDING KINETICS; CONTROLLED STUDY; ERYTHROID CELL; GENE CONTROL; GENE LOCUS; HUMAN; HUMAN CELL; INTRON; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION;

CARRIER PROTEINS; ERYTHROID CELLS; FETAL HEMOGLOBIN; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GENETIC LOCI; HEMOGLOBINOPATHIES; HISTONES; HUMANS; K562 CELLS; NUCLEAR PROTEINS; REGULATORY ELEMENTS, TRANSCRIPTIONAL;

EID: 77955271206     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2010.05.006     Document Type: Article

References (40)

1. Platt O.S., Brambilla D.J., Rosse W.F., et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N. Engl. J. Med. 1994, 330:1639-1644.
2. Ho P.J., Hall G.W., Luo L.Y., Weatherall D.J., Thein S.L. Beta-thalassaemia intermedia: is it possible consistently to predict phenotype from genotype?. Br. J. Haematol. 1998, 100:70-78.
3. Garner C., Tatu T., Reittie J.E., et al. Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood 2000, 95:342-346.
4. Menzel S., Garner C., Gut I., et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat. Genet. 2007, 39:1197-1199.
5. Lettre G., Sankaran V.G., Bezerra M.A., et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:11869-11874.
6. Uda M., Galanello R., Sanna S., et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1620-1625.
7. Sedgewick A.E., Timofeev N., Sebastiani P., et al. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies. Blood Cells Mol. Dis. 2008.
8. Saiki Y., Yamazaki Y., Yoshida M., Katoh O., Nakamura T. Human EVI9, a homologue of the mouse myeloid leukemia gene, is expressed in the hematopoietic progenitors and down-regulated during myeloid differentiation of HL60 cells. Genomics 2000, 70:387-391.
9. Liu P., Keller J.R., Ortiz M., et al. Bcl11a is essential for normal lymphoid development. Nat. Immunol. 2003, 4:525-532.
10. Satterwhite E., Sonoki T., Willis T.G., et al. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 2001, 98:3413-3420.
11. Sankaran V.G., Menne T.F., Xu J., et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 2008, 322:1839-1842.
12. Jiang J., Best S., Menzel S., et al. cMYB is involved in the regulation of fetal hemoglobin production in adults. Blood 2006, 108:1077-1083.
13. Sankaran V.G., Xu J., Ragoczy T., et al. Developmental and species-divergent globin switching are driven by BCL11A. Nature 2009, 460:1093-1097.
14. Chen Z., Luo H.Y., Steinberg M.H., Chui D.H. BCL11A represses HBG transcription in K562 cells. Blood Cells Mol. Dis. 2009, 42:144-149.
15. Wahlberg K., Jiang J., Rooks H., et al. The HBS1L-MYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cells. Blood 2009, 114:1254-1262.
16. Fibach E., Manor D., Oppenheim A., Rachmilewitz E.A. Proliferation and maturation of human erythroid progenitors in liquid culture. Blood 1989, 73:100-103.
17. Gribnau J., Diderich K., Pruzina S., Calzolari R., Fraser P. Intergenic transcription and developmental remodeling of chromatin subdomains in the human beta-globin locus. Mol. Cell 2000, 5:377-386.
18. Miles J., Mitchell J.A., Chakalova L., et al. Intergenic transcription, cell-cycle and the developmentally regulated epigenetic profile of the human beta-globin locus. PLoS ONE 2007, 2:e630.
19. Nicolis S., Bertini C., Ronchi A., et al. An erythroid specific enhancer upstream to the gene encoding the cell-type specific transcription factor GATA-1. Nucleic Acids Res. 1991, 19:5285-5291.
20. Tsai S.F., Strauss E., Orkin S.H. Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter. Genes Dev. 1991, 5:919-931.
21. Bank A. Regulation of human fetal hemoglobin: new players, new complexities. Blood 2006, 107:435-443.
22. Wainscoat J.S., Thein S.L., Wood W.G., et al. A novel deletion in the beta-globin gene complex. Ann. N.Y. Acad. Sci. 1985, 445:20-27.
23. Calzolari R., McMorrow T., Yannoutsos N., Langeveld A., Grosveld F. Deletion of a region that is a candidate for the difference between the deletion forms of hereditary persistence of fetal hemoglobin and deltabeta-thalassemia affects beta- but not gamma-globin gene expression. EMBO J. 1999, 18:949-958.
24. Chakalova L., Osborne C.S., Dai Y.F., et al. The Corfu deltabeta thalassemia deletion disrupts gamma-globin gene silencing and reveals post-transcriptional regulation of HbF expression. Blood 2005, 105:2154-2160.
25. Solovieff N., Milton J.N., Hartley S.W., et al. Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster. Blood 2010, 115:1815-1822.
26. Feingold E.A., Forget B.G. The breakpoint of a large deletion causing hereditary persistence of fetal hemoglobin occurs within an erythroid DNA domain remote from the beta-globin gene cluster. Blood 1989, 74:2178-2186.
27. Katsantoni E.Z., Langeveld A., Wai A.W., et al. Persistent gamma-globin expression in adult transgenic mice is mediated by HPFH-2, HPFH-3, and HPFH-6 breakpoint sequences. Blood 2003, 102:3412-3419.
28. Hughes J.R., Cheng J.F., Ventress N., et al. Annotation of cis-regulatory elements by identification, subclassification, and functional assessment of multispecies conserved sequences. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:9830-9835.
29. Vernimmen D., Marques-Kranc F., Sharpe J.A., et al. Chromosome looping at the human {alpha}-globin locus is mediated via the major upstream regulatory element (HS-40). Blood 2009, 114:4253-4260.
30. De Gobbi M., Anguita E., Hughes J., et al. Tissue-specific histone modification and transcription factor binding in alpha globin gene expression. Blood 2007, 110:4503-4510.
31. Letting D.L., Chen Y.Y., Rakowski C., Reedy S., Blobel G.A. Context-dependent regulation of GATA-1 by friend of GATA-1. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:476-481.
32. Hong W., Nakazawa M., Chen Y.Y., et al. FOG-1 recruits the NuRD repressor complex to mediate transcriptional repression by GATA-1. EMBO J. 2005, 24:2367-2378.
33. Rodriguez P., Bonte E., Krijgsveld J., et al. GATA-1 forms distinct activating and repressive complexes in erythroid cells. EMBO J. 2005, 24:2354-2366.
34. Harju-Baker S., Costa F.C., Fedosyuk H., Neades R., Peterson K.R. Silencing of Agamma-globin gene expression during adult definitive erythropoiesis mediated by GATA-1-FOG-1-Mi2 complex binding at the -566 GATA site. Mol. Cell. Biol. 2008, 28:3101-3113.
35. Kim J., Sif S., Jones B., et al. Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity 1999, 10:345-355.
36. Georgopoulos K., Bigby M., Wang J.H., et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell 1994, 79:143-156.
37. Lopez R.A., Schoetz S., DeAngelis K., O'Neill D., Bank A. Multiple hematopoietic defects and delayed globin switching in Ikaros null mice. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:602-607.
38. O'Neill D., Yang J., Erdjument-Bromage H., et al. Tissue-specific and developmental stage-specific DNA binding by a mammalian SWI/SNF complex associated with human fetal-to-adult globin gene switching. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:349-354.
39. O'Neill D.W., Schoetz S.S., Lopez R.A., et al. An ikaros-containing chromatin-remodeling complex in adult-type erythroid cells. Mol. Cell. Biol. 2000, 20:7572-7582.
40. Bottardi S., Ross J., Bourgoin V., et al. Ikaros and GATA-1 combinatorial effect is required for silencing of human gamma-globin genes. Mol. Cell. Biol. 2009, 29:1526-1537.